Increasing Anticoagulant Therapy Procedures Reassure the Market Space for Fibrinogen Testing Reagents
Anticoagulant therapy includes various conventional drugs as well as new oral rapid-acting drugs that are used by patients, annually, to treat various conditions such as deep vein thrombosis, pulmonary embolism, and genetic clotting disorders. Just to screen the efficiency of anticoagulants, consistent blood tests such as fibrinogen, PT, and D-dimer are done through coagulation analyzers.
The treatment needs to be monitored regularly, and is usually recorded in an anticoagulant therapy record book. The dosage of the anticoagulant drug is recommended depending upon the blood monitoring results. This is anticipated to propel the growth of the global fibrinogen testing reagents market during the forecast period.
Find Out More about the Report Coverage
- Thermo Fisher Scientific Inc.
- Helena Laboratories Corporation
- TULIP DIAGNOSTICS (P) LTD
- Biosystems S.A.
- Randox Laboratories Ltd.
- Medirox AB
- Enzyme Research Laboratories(r2 Diagnostics)
- Kamiya biomedical Company
- Pathway Diagnostics Limited
Rise in Blood Clotting Disorders Creates a More Diverse Patient Pool for Fibrinogen Testing
According to a study published in Nature Review, deep vein thrombosis, a blood clotting disorder, is the major cause for mortality and morbidity in Europe. The incidence rate of this disease is around 104 to 183 per 100,000, per year, in Europe. The high incidence rate of this disorder is a major factor that is projected to drive the growth of the fibrinogen testing reagents market during the forecast period.
Furthermore, high health care expenditure and new entrants in the region are the other factors that are contributing to the growth of the fibrinogen testing reagents market in this region. Also, the assurance of patient safety due to the trending use of disposable consumables and reliable results are attributed to the growth of the fibrinogen testing reagents market in Europe.
The high adoption rate of automated and technological advanced coagulation instruments and reagents, high demand for faster results, and spontaneous testing are also projected to drive the growth of the fibrinogen testing reagents market during the forecast period in the region.
Also, the increasing privatization of diagnostic laboratories, value-added services, and user convenience are likely to fuel the growth of the fibrinogen testing reagents market during the forecast period.
Customize this Report
Explore Intelligence Tailored to Your Business Goals.
Manufacturers of Fibrinogen Testing Reagents Targeting Developing Economies for Better Product Marketing and Fresh Consumer Pools
There has been a gradual increase in the number of manufacturers of fibrinogen testing reagents who are investing in the Asia Pacific region. Moreover, the vulnerable population and high unmet diagnostic needs have gathered more market attention.
Asia Pacific is one of the fastest developing regions for fibrinogen testing reagents. Factors such as high per capita income, increased disposable income, and improving healthcare infrastructure uplift the growth of the fibrinogen testing reagents market. Regional factors are responsible for the increased consumption of diagnostic and therapy products.
An increasing number of diagnostic labs and point of care testing in countries such as Saudi Arabia and South Africa is expected to boost the growth of the MEA fibrinogen testing reagents market over the forecast period.
Market Research Methodology - Perfected through Years of Diligence
A key factor for our unrivaled market research accuracy is our expert- and data-driven research methodologies. We combine an eclectic mix of experience, analytics, machine learning, and data science to develop research methodologies that result in a multi-dimensional, yet realistic analysis of a market.
High Cost of Equipment & Low Awareness of Concerned Testing Continue to Pose Negative Impact on Growth of Fibrinogen Testing Reagents Market
Bleeding disorders account for a significant share of various diseases in developing countries. A study published in the Blood Journal in 2013 stated that, in a few developing countries in the Middle East such as Iran, consanguineous marriages are high, and the prevalence of bleeding disorders is also high.
Many studies have shown that, around 60% to 70% of deep vein thrombosis is clinically undiagnosed in developing countries. End stage liver disease is taking a huge toll on the present population, and with the presently adopted lifestyles, the disease is projected to increase, creating an impact on the fibrinogen testing reagents market.
Lack of awareness in developing countries (China, India, and others) is expected to hinder the growth of the global fibrinogen testing reagents market. Affordability issues in China and India are expected to create a dip in the overall market value potential, and such a scenario may hamper the growth of the overall fibrinogen testing reagents market during the forecast period.
Explore Persistence Market Research’s expertise in promulgation of the business !
Fibrinogen Testing Reagents Market: Competitive Landscape
The competition section of the report features the profiles of the key players in the fibrinogen testing reagents market based on their product offerings, market shares, marketing approach, and differential strategies. Some of the key players profiled include Siemens Healthcare GmbH, Thermo Fisher Scientific Inc., Grifols S.A., Helena Laboratories Corporation, Diagnostica Stago S.A.S., Tulip Diagnostics (P) Ltd., and Werfen.
Fibrinogen Testing Reagents Market: Definition
Fibrinogens are plasma proteins that are synthesized in the parenchymal tissue of the liver. Fibrinogen testing reagents are assay kits that are used in the quantitative determination of various hemorrhagic states or disorders in a clinical laboratory setting.
About the Report
PMR has conducted a research study on the fibrinogen testing reagents market for the forecast period 2018 to 2028. The report offers a comprehensive evaluation of the business opportunities prevailing in the fibrinogen testing reagents market, along with insights on key regulations, prevalence data, and pricing. The report also elaborates on the macro-economic factors influencing the dynamics of the fibrinogen testing reagents market.
Fibrinogen Testing Reagents Market: Segmentation
The report offers a comprehensive taxonomy of the fibrinogen testing reagents market based on reagent type, indication, end user, and region. By reagent type, the fibrinogen testing reagents market is segmented as Q.F.A. thrombin kits, multifibren U reagents, STA-fibrinogen kits, fibrinogen kits, and imidazole buffer kits.
Based on indication, the fibrinogen testing reagents market is segmented as congenital fibrinogen disorders, fibrinogen storage diseases, hereditary fibrinogenα-chain amyloidosis, acquired dysfibrinogenemia, cryofibrinogenemia, disseminated intravascular coagulation, and end-stage liver disease.
On the basis of end user, the fibrinogen testing reagents market is segmented as hospitals, clinics, diagnostic laboratories, ambulatory care centers, and academic & research institutes. The fibrinogen testing reagents market has been analysed across the regions of North America, Latin America, Europe, East Asia, South Asia, Oceania, and MEA.
Additional Questions Answered
Some of the additional questions addressed in this report on the fibrinogen testing reagents market are:
- What is the revenue potential of fibrinogen testing reagents across the countries of North America and Europe?
- Who are the key competitors in the fibrinogen testing reagents market, and what are their product portfolios and growth strategies?
- What are the major factors influencing the growth of the fibrinogen testing reagents market?
- Which trends are being followed by the leading manufacturers of fibrinogen testing reagents to retain their market share.